These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15031243)

  • 1. Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction.
    Dalal H; Evans PH; Campbell JL
    BMJ; 2004 Mar; 328(7441):693-7. PubMed ID: 15031243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary prevention following myocardial infarction: a clinical update.
    Isted A; Williams R; Oakeshott P
    Br J Gen Pract; 2018 Mar; 68(668):151-152. PubMed ID: 29472228
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of an acute coronary syndrome pathway to improve adherence to secondary prevention guidelines.
    Biviano AB; Rabbani LE; Paultre F; Hurley E; Sullivan J; Giglio J; Mosca L
    Am J Cardiol; 2003 May; 91(10):1248-50. PubMed ID: 12745113
    [No Abstract]   [Full Text] [Related]  

  • 4. Secondary prevention after acute myocardial infarction and coronary revascularisation: focus on Angiotensin converting enzyme inhibitors.
    Kaski JC; Fernandez-Berges D
    Cardiovasc Drugs Ther; 2008 Jun; 22(3):185-91. PubMed ID: 18317916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial.
    Ivers NM; Schwalm JD; Bouck Z; McCready T; Taljaard M; Grace SL; Cunningham J; Bosiak B; Presseau J; Witteman HO; Suskin N; Wijeysundera HC; Atzema C; Bhatia RS; Natarajan M; Grimshaw JM
    BMJ; 2020 Jun; 369():m1731. PubMed ID: 32522811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention of ischaemic cardiac events.
    Gami A
    Clin Evid; 2006 Jun; (15):195-228. PubMed ID: 16973010
    [No Abstract]   [Full Text] [Related]  

  • 7. Ask the doctor. I had a heart attack three years ago at age 78. My doctor started me on lisinopril, carvedilol, and aspirin. My total cholesterol is 190, and my LDL is 128. Should I be taking a statin?
    Lee R
    Harv Heart Lett; 2011 Aug; 21(12):7. PubMed ID: 21991614
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacotherapy after cardiac infarction].
    Darius H; Meyer J
    Internist (Berl); 2001 May; 42(5):699-712. PubMed ID: 11400577
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary prevention for patients following a myocardial infarction: summary of NICE guidance.
    Skinner JS; Cooper A; Feder GS;
    Heart; 2007 Jul; 93(7):862-4. PubMed ID: 17569811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance.
    Jones K; Saxon L; Cunningham W; Adams P;
    BMJ; 2013 Nov; 347():f6544. PubMed ID: 24227827
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacotherapy following myocardial infarction].
    Spinarová L; Spinar J; Vítovec J
    Vnitr Lek; 2011 Nov; 57(11):966-9. PubMed ID: 22165705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Unrecognized myocardial infarction].
    Matsumoto T
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():249-52. PubMed ID: 17952999
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological prevention of coronary relapses in Italian clinical practice: a literature review].
    Pedrinelli R; Ciccone M; Novo S; Catapano AL
    G Ital Cardiol (Rome); 2012 Nov; 13(11):734-40. PubMed ID: 23096582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.
    Nakao K; Yasuda S; Nishimura K; Noguchi T; Nakai M; Miyamoto Y; Sumita Y; Shishido T; Anzai T; Ito H; Tsutsui H; Saito Y; Komuro I; Ogawa H
    J Am Heart Assoc; 2019 Apr; 8(7):e009692. PubMed ID: 30909774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can preventive therapy alter the initial presentation of coronary heart disease?
    Smith SC
    Ann Intern Med; 2006 Feb; 144(4):296-7. PubMed ID: 16490916
    [No Abstract]   [Full Text] [Related]  

  • 16. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
    Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding ACE inhibitors or ARBs to standard therapy for stable ischemic heart disease.
    Guirguis-Blake J
    Am Fam Physician; 2012 Jul; 86(1):21-3. PubMed ID: 22962909
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of in-hospital cardiac rehabilitation program on medication adherence and clinical outcomes in patients with acute myocardial infarction in the Lazio region of Italy.
    Soldati S; Di Martino M; Rosa AC; Fusco D; Davoli M; Mureddu GF
    BMC Cardiovasc Disord; 2021 Sep; 21(1):466. PubMed ID: 34565326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on NICE guidance for secondary prevention for patients following a myocardial infarction.
    Skinner JS; Minhas R
    Heart; 2007 Jul; 93(7):864-6. PubMed ID: 17569812
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.
    Mathews R; Wang TY; Honeycutt E; Henry TD; Zettler M; Chang M; Fonarow GC; Peterson ED;
    Am Heart J; 2015 Jul; 170(1):62-9. PubMed ID: 26093865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.